Investment
Features
FeesSafety
Academy
More
Pluang+

Dogecoin stalls near $0.093 after failing to break key $0.098 resistance level

Market News
04 Oct 2026
Coinpaper
View Source
Neutral
Dogecoin stalls near $0.093 after failing to break key $0.098 resistance level

Dogecoin (DOGE) reached a high of about $0.0976 on October 2 but failed to break through the crucial resistance level around $0.098-$0.10, closing near $0.093. Despite strong buying from large holders and $2.9 million inflows into U.S. Dogecoin investment products, the price retreated to support near $0.092-$0.093. A successful breakout above $0.098 is needed for a larger upward move, with $0.11-$0.12 as the next potential target. However, a drop below $0.09 could lead to a deeper pullback.

Dogecoin price action provides context for cryptocurrency markets. For readers following crypto, here is Pluang's market snapshot as of Oct 04, 2026 19:21 WIB: 33 of 50 major cryptocurrencies rose today, 16 fell. Notable movers include BCH at Rp5.678.905 (+2.34%), BNB at Rp14.085.491 (+2.31%), and XTZ at Rp5.772 (+2.16%).

More News

SpaceX stock has only once closed above $200; forecast says it will happen again by 2028.

SpaceX stock has only once closed above $200; forecast says it will happen again by 2028.

SpaceX's stock price has reached a closing value above $200 only one time so far. Analysts predict that the stock will close above this $200 mark again before the year 2028. This forecast suggests potential growth and renewed investor interest in Spa...

Analyst Insights
Bullish
3 hours ago
Pyxis Oncology advances MICVO cancer drug with promising early data and strong financing for Phase 3 trials

Pyxis Oncology advances MICVO cancer drug with promising early data and strong financing for Phase 3 trials

Pyxis Oncology is developing MICVO, an antibody-drug conjugate aimed at targeting tissues around tumors to kill cancer cells. Early clinical data for MICVO has been promising, but the company still needs to determine a safe and effective dosage. Rece...

Market News
Bullish
4 hours ago
Nike stock upgraded to Buy with 52% upside despite recent weak earnings and challenges.

Nike stock upgraded to Buy with 52% upside despite recent weak earnings and challenges.

Freedom Broker upgraded Nike shares from Sell to Buy, citing confidence in the company's long-term turnaround strategy despite weak near-term results. Nike's stock has fallen about 53% over the past year, but the new $51 price target implies a 52% up...

Analyst Insights
Bullish
4 hours ago
Ethereum struggles to break $2,800 amid weak ETF demand but eyes $3,000 with upcoming Glamsterdam upgrade.

Ethereum struggles to break $2,800 amid weak ETF demand but eyes $3,000 with upcoming Glamsterdam upgrade.

Ethereum (ETH) closed near $2,687 on Oct. 4, failing to sustain a breakout above the key $2,800 resistance level that could lead to a push toward $3,000. Institutional demand has weakened, with U.S. spot Ethereum ETFs seeing net outflows over three c...

Market News
Neutral
4 hours ago
A $1,000 investment in Marvell in 2016 grew 2140% despite major stock dips.

A $1,000 investment in Marvell in 2016 grew 2140% despite major stock dips.

Investing $1,000 in Marvell Technology in 2016 would have turned into about $22,400 by 2026, a 2140% return. The company shifted from selling storage and networking chips to supplying critical AI data center components, driving strong revenue growth....

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App